http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
CAMPBELL, JAMES D.,KWON, YONG JUNG 韓國自然史博物學會 1981 生物과 自然 Vol.11 No.1
한국에서는 처음으로 기록되는 물삿갓벌레科(Psephenidae)의 Mataeopsephenus japonicus sasajii SATO, 1970 (물삿갓벌레 : 신칭)를 채집하였으므로 이에 보고한다. 본종은 유충時 수중고착생활을 하며 원아종은 일본본토 각지 계류에 분포하고 있고, 본아종은 대마도에서 기록되었으며 체형과 생식기의 차이에 의해 확실히 구별되고, 서식처의 제한성등으로 미루어보아 일본열도가 먼저 대륙으로부터 격리된 후에 원아종 개체군이 일본본토에 형성되어 원종에서 분화되었고, 다시 본아종 개체군이 형성된 후에 대마도가 한반도에서 격리되었음을 입증하는 새로운 동물지리분포 자료로 사료된다. The first record of the species, Mataeopsephenus japonicus sasajii Sato, 1970 from the Korean Peninsula is reported. Photographs of the dorsal feature and the male genitalia are included.
( Yanhong Liu ),( Jeehwan Choe ),( Sheena Kim ),( Byeonghyeon Kim ),( Joy M. Campbell ),( Javier Polo ),( Joe D. Crenshaw ),( James E. Pettigrew ),( Minho Song ) 한국축산학회(구 한국동물자원과학회) 2018 한국축산학회지 Vol.60 No.6
Background: Stress causes inflammation that impairs intestinal barrier function. Dietary spray-dried plasma (SDP) has recognized anti-inflammatory effects and improvement of gut barrier function. Therefore, the purpose of this study was to investigate the effects of dietary SDP on intestinal morphology of mated female mice under stress condition. Results: Villus height, width, and area of small intestines were low on gestation day (GD) 3 or 4 under stress conditions, and higher later (Time, P < 0.05). Crypt depth of colon was low on GD 4 and higher later (Time, P < 0.05). Meanwhile, the SDP treatments improved (P < 0.05) intestinal morphology, indicated by increased villus height, villus width, villus area, and ratio between villus height and crypt depth of small intestines and crypt depth of colon, and by decreased crypt depth of small intestines, compared with the control diet. The SDP treatments also increased (P < 0.05) the number of goblet cells in intestines compared with the control diet. There were no differences between different levels of SDP. Conclusion: Dietary SDP improves intestinal morphology of mated female mice under stress condition.
Roder, David M.,Silva, Primali De,Zorbas, Helen N.,Webster, Fleur,Kollias, James,Pyke, Chris M.,Campbell, Ian D. Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.4
Aim: The study aim was to determine the frequency with which women decline clinicians' treatment recommendations and variations in this frequency by age, cancer and service descriptors. Design: The study included 36,775 women diagnosed with early invasive breast cancer in 1998-2005 and attending Australian and New Zealand breast surgeons. Rate ratios for declining treatment were examined by descriptor, using bilateral and multiple logistic regression analyses. Proportional hazards regression was used in exploratory analyses of associations with breast cancer death. Results: 3.4% of women declined a recommended treatment of some type, ranging from 2.6% for women under 40 years to 5.8% for those aged 80 years or more, and with parallel increases by age presenting for declining radiotherapy (p<0.001) and axillary surgery (p=0.006). Multiple regression confirmed that common predictors of declining various treatments included low surgeon case load, treatment outside major city centres, and older age. Histological features suggesting a favourable prognosis were often predictive of declining various treatments, although reverse findings also applied with women with positive nodal status being more likely to decline a mastectomy and those with larger tumours more likely to decline chemotherapy. While survival analyses lacked statistical power due to small numbers, higher risks of breast cancer death were suggested, after adjusting for age and conventional clinical risk factors, (1) for women not receiving breast surgery for unstated reasons (RR=2.29; p<0.001); and (2) although not approaching statistical significance $p{\geq}0.200$), for women declining radiotherapy (RR=1.22), a systemic therapy (RR1.11), and more specifically, chemotherapy (RR=1.41). Conclusions: Women have the right to choose their treatments but reasons for declining recommendations require further study to ensure that choices are well informed and clinical outcomes are optimized.